Podcast

December 19, 2019

'Speaking Out' on Legal Protection in Cancer

Author(s):

Kristie L. Kahl

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lisa Schlager, from FORCE, about the types of legal protections in place for those with a genetic risk for cancer.

In the United States, there are specific laws in place to protect those who have received a cancer diagnosis as well as for those who are at an increased risk for hereditary cancer. In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lisa Schlager, from Facing Our Risk of Cancer Empowered (FORCE), to help break down the types of legal protections in place for these individuals.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

Image of woman.

Sue Friedman in an interview with CURE

Dr. Alex Francoeur interviewing against a gray CURE background

Related Content

Image of injection.

June 12th 2025

How Love Helped Me Overcome my Cancer Diagnosis

Glenna Sears-Brinker

Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination to save my life.

March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Image of kelly.

May 23rd 2025

Ovarian Cancer Treatment Side Effects Make for a Difficult Balancing Act

I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.

March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Kelly Irvin was diagnosed with stage 4 ovarian cancer in January 2016. Catch up on all of Kelly's blogs here!

May 6th 2025

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.

Illustration of ovary.

May 2nd 2025

First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.

Related Content

Image of injection.

June 12th 2025

How Love Helped Me Overcome my Cancer Diagnosis

Glenna Sears-Brinker

Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination to save my life.

March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Image of kelly.

May 23rd 2025

Ovarian Cancer Treatment Side Effects Make for a Difficult Balancing Act

I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.

March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Kelly Irvin was diagnosed with stage 4 ovarian cancer in January 2016. Catch up on all of Kelly's blogs here!

May 6th 2025

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.

Illustration of ovary.

May 2nd 2025

First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.

Advertise / Support

Editorial Board

CancerNetwork.com

TargetedOnc.com

OncNursingNews.com

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.